SC 13D Filing

Company

IOVANCE BIOTHERAPEUTICS, INC.

Filed

March 24, 2010

Accession Number

0001144204-10-015401

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →